What is Advanced BioMedical Technologies Inc. (ABMT) stock price today?

Advanced BioMedical Technologies Inc. (ABMT) is currently trading at $0.00.

What is ABMT P/E ratio?

Advanced BioMedical Technologies Inc.'s P/E ratio is -0.07. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is ABMT return on equity (ROE)?

Advanced BioMedical Technologies Inc.'s return on equity (ROE) is 12.50%. ROE measures net income relative to shareholders' equity. Shareholders' equity is negative, so ROE is not a meaningful measure for this company.

What is Advanced BioMedical Technologies Inc.'s market cap?

Advanced BioMedical Technologies Inc. has a market capitalization of $50000.

OTC · Medical - Devices

Advanced BioMedical Technologies Inc. (ABMT) Stock

$0.00 OTC: ABMT Healthcare

Valuation

Metric	Value
Price	$0.00
Market Cap	$50000
P/E Ratio	-0.07
P/B Ratio	0.00
P/S Ratio	0.32
EPS (TTM)	$0.00
52-Week High	$0.00
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	12.50%
ROA	-78.11%
ROCE	2.27%
Gross Margin	74.32%
Operating Margin	-66.38%
Net Margin	0.00%
Debt/Equity	-0.87
Current Ratio	0.03

Annual Financials (USD)

Metric	2018	2019	2020	2021	2022
Revenue	$0	$0	$0	$0	$0
Operating Profit	$-1.0M	$-1.0M	$0	$0	$0
Net Profit	$-1.0M	$-1.0M	$-1.0M	$-1.0M	$-1.0M
EPS	$-0.01	$-0.01	$-0.01	$-0.01	$-0.01
Op Margin	—	-5187.8%	-361.4%	-230.7%	-66.4%

Balance Sheet (USD)

Metric	2018	2019	2020	2021	2022
Total Assets	$0	$0	$0	$0	$0
Total Liabilities	$6.0M	$7.0M	$8.0M	$9.0M	$8.0M
Cash	$0	$0	$0	$0	$0
Borrowings	$4.0M	$5.0M	$5.0M	$7.0M	$7.0M

Cash Flow (USD)

Metric	2018	2019	2020	2021	2022
Operating Cash Flow	$-1.0M	$-1.0M	$1.0M	$-1.0M	$-1.0M
Investing Cash Flow	$0	$0	$0	$0	$0
Financing Cash Flow	$1.0M	$1.0M	$0	$0	$0
Net Cash Flow	$0	$0	$0	$0	$0
Free Cash Flow	$-1.0M	$-1.0M	$1.0M	$-1.0M	$-1.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-41.30
FCF Yield	-1469.06%
Quick Ratio	0.01
Interest Coverage	-0.54
Return 1Y	400.00%
Return 3Y	-98.59%
Return 5Y	—

Ownership

Insiders Held3.31%

Institutions Held0.00%

Institutions Float Held0.00%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ASFXAmerican Scientific Resources, Incorporated	$0.00	—	—	$5251	0.00%
ECGIECGI Holdings, Inc.	$0.00	—	-0.03	$3445	0.00%
FIORFFiore Cannabis Ltd.	$0.00	—	0.00	$1971	0.00%
HSMDHealthcare Solutions Management Group, Inc.	$0.00	—	0.00	$18443	0.00%
MDXLMedixall Group, Inc.	$0.01	+0.00%	-0.15	$1.15M	0.00%

About Advanced BioMedical Technologies Inc.

Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures. The company was formerly known as Geostar Mineral Corporation and changed its name to Advanced Biomedical Technologies, Inc. in March 2009. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York.

Advanced BioMedical Technologies Inc. (ABMT) stock trades at $0.00 with a market capitalization of $50000. The stock is valued at a negative price-to-earnings (P/E) ratio of -0.07, reflecting a net loss over the last twelve months, price-to-book of 0.00, price-to-sales of 0.32.

On profitability, Advanced BioMedical Technologies Inc. generates a return on equity (ROE) of 12.50% (not meaningful, as shareholders' equity is negative), return on capital employed of 2.27%, an operating margin of -66.38%.

Official website: abtlafleur.com

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Related stock screens

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.